Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Kalaycio

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Current Hematology Reports|December 30, 2003
A new standard treatment for chronic myelogenous leukemiaMatt Kalaycio
Cancer|January 2, 2009
Bendamustine: a new look at an old drugMatt Kalaycio
Cleveland Clinic Journal of Medicine|August 10, 2016
Your patient has chronic leukemia: Now what?Matt Kalaycio
Current Hematologic Malignancy Reports|April 29, 2010
Initial chemotherapy for chronic lymphocytic leukemia: what's the standard of care?Matt Kalaycio
Current Hematology Reports|December 30, 2003
Hematopoietic growth factors for acute myelogenous leukemiaMatt Kalaycio
Current Hematology Reports|December 22, 2004
Induction chemotherapy for acute myelogenous leukemiaMatt Kalaycio
Current Hematologic Malignancy Reports|March 3, 2016
Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic PhaseSudipto Mukherjee, Matt Kalaycio
Leukemia & Lymphoma|July 15, 2006
Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimesterRevathi Suppiah, Matt Kalaycio
Leukemia Research|June 22, 2013
Fludarabine: a review of the clear benefits and potential harmsJoshua Lukenbill, Matt Kalaycio
Expert Review of Anticancer Therapy|July 13, 2002
Treatment of refractory and relapsed acute myelogenous leukemiaSlobodan Stanisic, Matt Kalaycio
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Current Hematology Reports|December 30, 2003
A new standard treatment for chronic myelogenous leukemiaMatt Kalaycio
Cancer|January 2, 2009
Bendamustine: a new look at an old drugMatt Kalaycio
Cleveland Clinic Journal of Medicine|August 10, 2016
Your patient has chronic leukemia: Now what?Matt Kalaycio
Current Hematologic Malignancy Reports|April 29, 2010
Initial chemotherapy for chronic lymphocytic leukemia: what's the standard of care?Matt Kalaycio
Current Hematology Reports|December 30, 2003
Hematopoietic growth factors for acute myelogenous leukemiaMatt Kalaycio
Current Hematology Reports|December 22, 2004
Induction chemotherapy for acute myelogenous leukemiaMatt Kalaycio
Current Hematologic Malignancy Reports|March 3, 2016
Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic PhaseSudipto Mukherjee, Matt Kalaycio
Leukemia & Lymphoma|July 15, 2006
Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimesterRevathi Suppiah, Matt Kalaycio
Leukemia Research|June 22, 2013
Fludarabine: a review of the clear benefits and potential harmsJoshua Lukenbill, Matt Kalaycio
Expert Review of Anticancer Therapy|July 13, 2002
Treatment of refractory and relapsed acute myelogenous leukemiaSlobodan Stanisic, Matt Kalaycio
Pageof 16